Patungan, Nahda M.

HRN: 21-13-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFUROXIME 1.5GM (VIAL)
12/12/2023
12/12/2023
IV
1.5gm
Now
T/c Incomplete Abortion
Checking Final Appropriateness 
12/12/2023
CEFUROXIME 750MG (VIAL)
12/12/2023
12/18/2023
IV
750mg
Q8hr
Incomplete Abortion
Checking Final Appropriateness 
12/15/2023
CEFUROXIME 500MG (TAB)
12/15/2023
12/22/2023
PO
1 Tab
BID
SP Completion Curettage
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: